Summary

The global healthcare supply chain management market is projected to reach USD 5.31 billion by 2031 from USD 4.13 billion in 2026, at a CAGR of 5.1% during the forecast period. Growing demand for supply chain transparency and traceability is driving adoption of healthcare supply chain management solutions as organizations seek greater visibility into the movement, availability, and status of medical products across the supply chain. Complex supplier networks, increasing product volumes, and the need to ensure product quality and authenticity are encouraging healthcare organizations to strengthen tracking and data-sharing capabilities. Supply chain management solutions enable organizations to monitor procurement, inventory, warehousing, distribution, and product movement, providing greater visibility across supply chain activities. Technologies such as RFID, barcode systems, cloud-based platforms, and real-time analytics further support product tracking and information exchange, helping organizations improve inventory accuracy, identify supply disruptions, strengthen compliance, and reduce the risk of product loss, diversion, or counterfeiting.

By product managed, the pharmaceutical and biotechnology segment accounted for the largest share of the healthcare supply chain management market in 2025.
Based on product managed, the healthcare supply chain management market is segmented into pharmaceutical and biotechnology, medical device and equipment, and other products managed. The pharmaceutical and biotechnology segment accounted for the largest share of the market in 2025, driven by the complex nature of pharmaceutical supply chains and the need to efficiently manage procurement, inventory, warehousing, distribution, and product tracking. Supply chain management solutions help pharmaceutical and biotechnology companies improve demand forecasting, optimize inventory levels, coordinate suppliers, and maintain visibility across product flows. The need for product traceability, regulatory compliance, inventory control, and timely availability of medicines and biologics further supports adoption. Increasing pharmaceutical and biotechnology production and the growing focus on supply chain resilience are also contributing to the segment's leading position.

By deployment model, the cloud-based model is expected to register the fastest growth in the healthcare supply chain management market during the forecast period.
Based on deployment model, the healthcare supply chain management market is segmented into on-premises model and cloud-based model. The cloud-based model is expected to register the fastest growth during the forecast period, supported by the increasing adoption of scalable and flexible supply chain technologies across healthcare organizations. Cloud-based solutions enable organizations to access supply chain data and applications across locations while supporting real-time visibility, collaboration, analytics, and integration with other enterprise systems. They can also reduce the need for extensive on-site IT infrastructure and facilitate faster deployment and system updates. The growing adoption of AI-enabled analytics, digital procurement, automated inventory management, and connected supply chain platforms is further supporting the shift toward cloud-based deployment.

By region, North America accounted for the largest share of the healthcare supply chain management market in 2025.
Based on region, the healthcare supply chain management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2025, supported by its established healthcare infrastructure, high healthcare expenditure, presence of major pharmaceutical and medical device companies, and strong adoption of digital supply chain technologies. Healthcare organizations in the region increasingly use supply chain management solutions to improve procurement, inventory optimization, supply chain visibility, and operational efficiency. Established healthcare supply chain technology providers and a growing emphasis on cost optimization, product traceability, and supply chain resilience further support market adoption.

The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation - Directors: 30%, Managers: 34%, and Others: 36%
- By Region - North America: 40%, Asia Pacific: 20%, Europe: 28%, Latin America: 7%, and Middle East & Africa: 5%
- SAP SE (Germany) and Oracle (US) are key players in the healthcare supply chain management market.
- The study includes an in-depth competitive analysis of these key players in the healthcare supply chain management market, with their company profiles, recent developments, and key market strategies.

Research Coverage:
The report analyzes the healthcare supply chain management market and aims to estimate the market size and future growth potential of various market segments, based on offering, function, product managed, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates market opportunities and challenges for stakeholders. The report also examines micro markets in terms of growth trends, prospects, and contributions to the total healthcare supply chain management market. The report forecasts revenue for the market segments across five major regions. The report also provides a competitive analysis of key players in this market, including company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
This report will help established firms and new entrants/smaller firms gauge the pulse of the market, which can help them gain a greater share of the market. Firms purchasing the report could use one or a combination of the strategies below to strengthen their market position.

This report provides insights on:
- Analysis of key drivers (increasing pressure on healthcare providers to improve operational efficiency and profitability, rising demand for healthcare services due to population growth and aging demographics, focus on reducing supply chain costs, demand for transparency and traceability, availability of funding, investments, and partnerships, large-scale drug counterfeiting in pharmaceutical industry), restraints (high implementation costs for advanced technologies, data security and privacy concerns, supply chain disruptions due to global events or geopolitical tensions), opportunities (increasing use of AI-powered solutions, expansion into emerging markets with growing healthcare demands, enhanced focus on sustainability and eco-friendly practices in healthcare logistics), challenges (complex and varying regulatory requirements across regions, shortage of skilled professionals to manage sophisticated systems) are factors contributing the growth of the healthcare supply chain management market.
- Product Development/Innovation: Detailed insights into upcoming trends, research & development activities, and new software launches in the healthcare supply chain management market.
- Market Development: Comprehensive information on the lucrative emerging markets, solution type, component, function, industry, and region.
- Market Diversification: Exhaustive information about the offering portfolios, growing geographies, recent developments, and investments in the healthcare supply chain management market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players: SAP SE (Germany), Oracle (US), IBM (US), Cardinal Health (US), and Infor (US).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.3 MARKET SCOPE 41
1.3.1 MARKETS COVERED 41
1.3.2 INCLUSIONS AND EXCLUSIONS 42
1.3.3 YEARS CONSIDERED 44
1.4 CURRENCY CONSIDERED 44
1.5 STAKEHOLDERS 44
1.6 SUMMARY OF CHANGES 45

2 EXECUTIVE SUMMARY 46
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 46
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 48
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 49
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 50
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 51

3 PREMIUM INSIGHTS 52
3.1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET OVERVIEW 52
3.2 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,
BY OFFERING AND COUNTRY 53
3.3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 54

4 MARKET OVERVIEW 55
4.1 INTRODUCTION 55
4.2 MARKET DYNAMICS 56
4.2.1 DRIVERS 56
4.2.1.1 Increasing pressure on healthcare providers to improve operational efficiency and profitability 56
4.2.1.2 Rising demand for healthcare services due to population growth and aging demographics 57
4.2.1.3 Focus on reducing supply chain costs 57
4.2.1.4 Demand for transparency and traceability 58
4.2.1.5 Availability of funding, investments, and partnerships 58
4.2.1.6 Large-scale drug counterfeiting in pharmaceutical industry 58
4.2.2 RESTRAINTS 59
4.2.2.1 High implementation costs for advanced technologies 59
4.2.2.2 Data security and privacy concerns 59
4.2.2.3 Supply chain disruptions due to global events or geopolitical tensions 60
4.2.3 OPPORTUNITIES 60
4.2.3.1 Increasing use of AI-powered solutions 60
4.2.3.2 Expansion into emerging markets with growing healthcare demands 61
4.2.3.3 Enhanced focus on sustainability and eco-friendly practices in healthcare logistics 61
4.2.4 CHALLENGES 62
4.2.4.1 Complex and varying regulatory requirements across regions 62
4.2.4.2 Shortage of skilled professionals to manage sophisticated systems 62
4.3 UNMET NEEDS AND WHITE SPACES 63
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 64
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 64

5 INDUSTRY TRENDS 66
5.1 PORTER'S FIVE FORCES ANALYSIS 66
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 67
5.1.2 BARGAINING POWER OF BUYERS 67
5.1.3 THREAT OF SUBSTITUTES 67
5.1.4 THREAT OF NEW ENTRANTS 68
5.1.5 BARGAINING POWER OF SUPPLIERS 68
5.2 MACROECONOMIC INDICATORS 68
5.2.1 INTRODUCTION 68
5.2.2 GDP TRENDS AND FORECAST 68
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 69
5.3 VALUE CHAIN ANALYSIS 69
5.3.1 RESEARCH & PRODUCT DEVELOPMENT 70
5.3.2 TECHNOLOGY INFRASTRUCTURE 70
5.3.3 PLATFORM DEVELOPMENT 70
5.3.4 DISTRIBUTION 71
5.3.5 MARKETING & SALES 71
5.3.6 POST-SALES SERVICES 71
5.4 ECOSYSTEM ANALYSIS 71
5.5 PRICING ANALYSIS 73
5.5.1 INDICATIVE PRICE OF HEALTHCARE SUPPLY CHAIN MANAGEMENT,
BY OFFERING (2025) 73
5.5.2 INDICATIVE PRICE FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT,
BY REGION (2025) 74
5.6 KEY CONFERENCES & EVENTS, 2026–2027 75
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 76
5.8 INVESTMENT AND FUNDING SCENARIO 77
5.9 CASE STUDY ANALYSIS 78
5.10 IMPACT OF US TARIFF OVERVIEW 80
5.10.1 INTRODUCTION 80
5.10.2 KEY TARIFF RATES 81
5.10.3 PRICE IMPACT ANALYSIS 82
5.10.4 IMPACT ON COUNTRY/REGION 82
5.10.4.1 US 82
5.10.4.2 Europe 82
5.10.4.3 Asia Pacific 82
5.10.5 IMPACT ON END USERS 83
5.10.5.1 Manufacturers 83
5.10.5.2 Distributors 83
5.10.5.3 Healthcare providers 83

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 84
6.1 KEY EMERGING TECHNOLOGIES 84
6.1.1 BLOCKCHAIN 84
6.1.2 ARTIFICIAL INTELLIGENCE & MACHINE LEARNING 84
6.1.3 CLOUD COMPUTING 85
6.2 COMPLEMENTARY TECHNOLOGIES 85
6.2.1 DATA ANALYTICS 85
6.2.2 INTERNET OF THINGS 85
6.3 ADJACENT TECHNOLOGIES 85
6.3.1 AR/VR 85
6.4 TECHNOLOGY/PRODUCT ROADMAP 86
6.5 PATENT ANALYSIS 86
6.5.1 PATENT PUBLICATION TRENDS 86
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 87
6.6 FUTURE APPLICATIONS 90
6.6.1 AI-ASSISTED PROCUREMENT AND PREDICTIVE INVENTORY MANAGEMENT 90
6.6.2 REAL-TIME SUPPLY CHAIN VISIBILITY AND INTELLIGENT AUTOMATION 91
6.6.3 PREDICTIVE SUPPLY CHAIN RISK MANAGEMENT AND RESILIENCE 91
6.7 IMPACT OF AI/GEN AI IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 91
6.7.1 KEY USE CASES 92
6.7.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 93
6.7.2.1 Case Study 1: Enhancing supply chain with AI Solutions at NHS Blood and Transplant 93
6.7.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 94
6.7.3.1 Case Study 2: Leveraging AI for Proactive Infection Prevention in Hospital 94
6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEM 95
6.7.4.1 Healthcare IT ecosystem 95
6.7.4.2 Supply chain management market 95
6.7.4.3 Cloud ERP market 96
6.7.5 USERS READINESS AND IMPACT ASSESSMENT 96
6.7.5.1 User readiness 96
6.7.5.1.1 User A: Manufacturers 96
6.7.5.1.2 User B: Distributors 96
6.7.5.1.3 User C: Providers 97
6.7.5.2 Impact assessment 97
6.7.5.2.1 User A: Manufacturers 97
6.7.5.2.1.1 Implementation 97
6.7.5.2.1.2 Impact 97
6.7.5.2.2 User B: Distributors 98
6.7.5.2.2.1 Implementation 98
6.7.5.2.2.2 Impact 98
6.7.5.2.3 User C: Providers 98
6.7.5.2.3.1 Implementation 98
6.7.5.2.3.2 Impact 99

7 REGULATORY LANDSCAPE 100
7.1 REGIONAL REGULATIONS AND COMPLIANCE 100
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 101
7.1.2 REGULATORY FRAMEWORK 104
7.1.2.1 North America 104
7.1.2.2 Europe 105
7.1.2.3 Asia Pacific 106
7.1.2.4 Middle East & Africa 108
7.1.2.5 Latin America 109
7.1.3 INDUSTRY STANDARDS 109

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 110
8.1 INTRODUCTION 110
8.2 DECISION-MAKING PROCESS 110
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 111
8.4 KEY STAKEHOLDERS IN BUYING PROCESS 112
8.4.1 KEY BUYING CRITERIA 113
8.5 ADOPTION BARRIERS & INTERNAL CHALLENGES 113
8.6 UNMET NEEDS FROM VARIOUS END USERS 114
8.6.1 UNMET NEEDS 114
8.6.2 END USER EXPECTATIONS 115
8.7 MARKET PROFITABILITY 116

9 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING 117
9.1 INTRODUCTION 118
9.2 SOFTWARE 118
9.2.1 ENTIRE SUPPLY CHAIN SUITES 120
9.2.1.1 Need for end-to-end visibility and real-time insights drives market growth 120
9.2.2 SUPPLY CHAIN PLANNING SOFTWARE 121
9.2.2.1 Need for effective and efficient supply chain planning to fuel market growth 121
9.2.3 SUPPLIER RELATIONSHIP MANAGEMENT (SRM) 122
9.2.3.1 Benefit of enhanced supplier collaboration to drive segment growth 122
9.2.4 SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT 124
9.2.4.1 Need for effective supply chain business network to drive growth of segment 124
9.2.5 SUPPLY CHAIN COST-TO-SERVE ANALYSIS 125
9.2.5.1 Pressing need to cut costs and improve operational efficiency to drive growth 125
9.2.6 SUPPLY CHAIN ANALYTICS SOFTWARE 126
9.2.6.1 Advancement of artificial intelligence in data analytics to drive market growth 126
9.2.7 SUPPLY CHAIN VISIBILITY SOFTWARE 127
9.2.7.1 Need for greater visibility and maintenance across supply chain to drive market growth 127
9.3 HARDWARE 129
9.3.1 BARCODES & BARCODE SCANNERS 130
9.3.1.1 Need for better tracking and traceability of medical devices to drive market growth 130
9.3.2 SYSTEMS 132
9.3.2.1 Advantages of smart cabinets in effective inventory management to drive segment growth 132
9.3.3 RFID TAGS & READERS 133
9.3.3.1 Crucial role of RFIDs in asset tracking, and inventory management to drive market growth 133
9.3.4 OTHER HARDWARE COMPONENTS 134
9.4 SERVICES 134
9.4.1 MANAGED SERVICES 136
9.4.1.1 Ability to focus on core business activities to drive demand for managed services 136
9.4.2 PROFESSIONAL SERVICES 137
9.4.2.1 Benefits of running supply chains with expert advice to drive demand for professional services 137

10 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION 138
10.1 INTRODUCTION 139
10.2 PURCHASING MANAGEMENT 139
10.2.1 SUPPLY MANAGEMENT 141
10.2.2 PROCUREMENT 142
10.2.3 CAPITAL PURCHASING 144
10.2.4 STRATEGIC SOURCING 145
10.2.5 TRANSPORTATION MANAGEMENT 146
10.3 INVENTORY MANAGEMENT 148
10.3.1 ORDER MANAGEMENT 150
10.3.2 WAREHOUSE MANAGEMENT 151
10.3.3 CONSIGNMENT MANAGEMENT 153
10.3.4 IMPLANT MANAGEMENT 154
10.3.5 TISSUE MANAGEMENT 156

11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,
BY PRODUCT MANAGED 157
11.1 INTRODUCTION 158
11.2 PHARMACEUTICAL & BIOTECHNOLOGY 158
11.2.1 DRIVING GROWTH IN HEALTHCARE THROUGH ADVANCED SUPPLY CHAIN SOLUTIONS FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS 158
11.2.2 SMALL MOLECULES 160
11.2.2.1 Driving growth through optimized supply chain solutions for small molecule drugs 160
11.2.3 VACCINES 161
11.2.3.1 Driving growth in healthcare through advanced solutions for vaccine distribution and innovation 161
11.2.4 MONOCLONAL ANTIBODIES, BIOSIMILARS & MRNA 163
11.2.4.1 Revolutionizing healthcare with advanced biotech therapies and evolving supply chain demands 163
11.2.5 CELL AND GENE THERAPY (CGT) 164
11.2.5.1 Driving innovation in cell and gene therapy through strategic supply chain solutions 164
11.2.6 OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS 165
11.3 MEDICAL DEVICES & EQUIPMENT 166
11.3.1 TRANSFORMING HEALTHCARE WITH ADVANCED MANAGEMENT OF MEDICAL DEVICES AND EQUIPMENT 166
11.3.2 SURGICAL INSTRUMENTS 168
11.3.2.1 Advancing surgical care through enhanced management of surgical instruments and logistics 168
11.3.3 DIAGNOSTICS & THERAPEUTICS EQUIPMENT 169
11.3.3.1 Revolutionizing patient care through advancements in diagnostics and therapeutics equipment 169
11.3.4 MONITORING DEVICES 170
11.3.4.1 Driving growth in healthcare through advanced monitoring devices and remote patient monitoring solutions 170
11.3.5 IMPLANTS & PROSTHETICS 172
11.3.5.1 Enhancing patient care through advanced monitoring devices and real-time health data management 172
11.3.6 OTHER MEDICAL DEVICES & EQUIPMENT 173
11.4 OTHERS 174

12 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,
BY DEPLOYMENT MODEL 175
12.1 INTRODUCTION 176
12.2 ON-PREMISE MODEL 176
12.3 CLOUD-BASED MODEL 178

13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER 180
13.1 INTRODUCTION 181
13.2 MANUFACTURERS 181
13.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 183
13.2.1.1 Complex regulatory requirements to drive growth of segment 183
13.2.2 MEDICAL & SURGICAL DEVICE MANUFACTURERS 184
13.2.2.1 Growing demand for medical devices and greater emphasis on supply chain resilience 184
13.3 DISTRIBUTORS 185
13.3.1 PRIMARY PHARMACEUTICAL DISTRIBUTORS 187
13.3.1.1 Expanding distribution infrastructure to improve pharmaceutical supply reliability 187
13.3.2 WHOLESALERS 188
13.3.2.1 Critical importance of wholesalers in bridging gap between manufacturers and end users to drive segment 188
13.3.3 GROUP PURCHASING ORGANIZATIONS (GPOS) 190
13.3.3.1 Role in optimizing supply chains by simplifying procurement processes to boost market growth 190
13.4 HEALTHCARE PROVIDERS 191
13.4.1 HOSPITALS & CLINICS 193
13.4.1.1 Need for efficient inventory management in hospitals to drive market growth 193
13.4.2 PHARMACIES 194
13.4.2.1 Ability to curb challenges faced by pharmacies in supply chain management to drive growth 194
13.4.3 AMBULATORY SURGICAL CENTERS 195
13.4.3.1 Effective inventory management to avoid overstocking or shortages to fuel the market expansion 195
13.4.4 OTHER HEALTHCARE PROVIDERS 197

14 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION 198
14.1 INTRODUCTION 199
14.2 NORTH AMERICA 199
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 200
14.2.2 US 207
14.2.2.1 Growing collaborations among market players to drive market 207
14.2.3 CANADA 214
14.2.3.1 increasing adoption of digital technologies to promote growth 214
14.3 EUROPE 221
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 222
14.3.2 GERMANY 229
14.3.2.1 Booming medical device market to propel market 229
14.3.3 UK 235
14.3.3.1 Key initiatives by NHS to drive market growth 235
14.3.4 FRANCE 242
14.3.4.1 Evolving digital health landscape to augment growth 242
14.3.5 SPAIN 248
14.3.5.1 Rise in chronic diseases to encourage growth 248
14.3.6 ITALY 255
14.3.6.1 Increasing initiatives in pharmaceutical and healthcare sectors to aid growth 255
14.3.7 NORDIC COUNTRIES 261
14.3.7.1 Increasing investments and expansion initiatives by prominent companies to accelerate growth 261
14.3.8 REST OF EUROPE 268
14.4 ASIA PACIFIC 275
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 275
14.4.2 JAPAN 283
14.4.2.1 Dominant aging population to accelerate growth 283
14.4.3 CHINA 290
14.4.3.1 Government Policies, and Technological Advancements Propel Growth in Healthcare Supply Chain 290
14.4.4 INDIA 296
14.4.4.1 Increasing healthcare access to spur growth 296
14.4.5 REST OF ASIA PACIFIC 303
14.5 LATIN AMERICA 310
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 310
14.5.2 BRAZIL 317
14.5.2.1 Regulatory demands to strengthen healthcare supply chain to drive growth 317
14.5.3 MEXICO 324
14.5.3.1 Growing foreign investment to boost market 324
14.5.4 REST OF LATIN AMERICA 330
14.6 MIDDLE EAST & AFRICA 337
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 337
14.6.2 GCC COUNTRIES 344
14.6.2.1 Rising healthcare investments to facilitate growth 344
14.6.3 REST OF MIDDLE EAST & AFRICA 351

15 COMPETITIVE LANDSCAPE 358
15.1 INTRODUCTION 358
15.2 KEY PLAYER STRATEGY/RIGHT TO WIN 358
15.3 REVENUE ANALYSIS, 2021–2025 362
15.4 MARKET SHARE ANALYSIS, 2025 363
15.5 BRAND/PRODUCT COMPARISON 366
15.6 COMPANY VALUATION & FINANCIAL METRICS 367
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 368
15.7.1 STARS 368
15.7.2 EMERGING LEADERS 368
15.7.3 PERVASIVE PLAYERS 368
15.7.4 PARTICIPANTS 368
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 370
15.7.5.1 Company footprint 370
15.7.5.2 Region footprint 371
15.7.5.3 Offering footprint 372
15.7.5.4 Function footprint 373
15.7.5.5 End user footprint 374
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 375
15.8.1 PROGRESSIVE COMPANIES 375
15.8.2 RESPONSIVE COMPANIES 375
15.8.3 DYNAMIC COMPANIES 375
15.8.4 STARTING BLOCKS 375
15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 377
15.9 COMPETITIVE SCENARIO 378
15.9.1 PRODUCT LAUNCHES & APPROVALS 378
15.9.2 DEALS 380
15.9.3 OTHER DEVELOPMENTS 383

16 COMPANY PROFILES 384
16.1 KEY PLAYERS 384
16.1.1 SAP SE 384
16.1.1.1 Business overview 384
16.1.1.2 Products/Services/Solutions offered 385
16.1.1.3 Recent developments 387
16.1.1.3.1 Product launches & upgrades 387
16.1.1.3.2 Deals 389
16.1.1.3.3 Expansions 392
16.1.1.4 MnM view 392
16.1.1.4.1 Right to win 392
16.1.1.4.2 Strategic choices 392
16.1.1.4.3 Weaknesses & competitive threats 392
16.1.2 ORACLE 393
16.1.2.1 Business overview 393
16.1.2.2 Products/Services/Solutions offered 394
16.1.2.3 Recent developments 396
16.1.2.3.1 Product launches & upgrades 396
16.1.2.3.2 Deals 398
16.1.2.3.3 Expansions 399
16.1.2.4 MnM view 400
16.1.2.4.1 Right to win 400
16.1.2.4.2 Strategic choices 400
16.1.2.4.3 Weaknesses & competitive threats 400
16.1.3 IBM 401
16.1.3.1 Business overview 401
16.1.3.2 Products/Services/Solutions offered 403
16.1.3.3 Recent developments 404
16.1.3.3.1 Product Launches & Upgrades 404
16.1.3.3.2 Deals 405
16.1.3.4 MnM view 407
16.1.3.4.1 Right to win 407
16.1.3.4.2 Strategic choices 407
16.1.3.4.3 Weaknesses & competitive threats 407
16.1.4 CARDINAL HEALTH 408
16.1.4.1 Business overview 408
16.1.4.2 Products/Services/Solutions offered 409
16.1.4.3 Recent developments 412
16.1.4.3.1 Product launches & upgrades 412
16.1.4.3.2 Deals 413
16.1.4.3.3 Expansions 415
16.1.4.4 MnM view 416
16.1.4.4.1 Right to win 416
16.1.4.4.2 Strategic choices 416
16.1.4.4.3 Weaknesses & competitive threats 416
16.1.5 INFOR 417
16.1.5.1 Business overview 417
16.1.5.2 Products/Services/Solutions offered 418
16.1.5.3 Recent developments 420
16.1.5.3.1 Product launches & upgrades 420
16.1.5.3.2 Deals 422
16.1.5.4 MnM view 423
16.1.5.4.1 Right to win 423
16.1.5.4.2 Strategic choices 423
16.1.5.4.3 Weaknesses & competitive threats 423
16.1.6 MANHATTAN ASSOCIATES 424
16.1.6.1 Business overview 424
16.1.6.2 Products/Services/Solutions offered 426
16.1.6.3 Recent developments 429
16.1.6.3.1 Product launches & upgrades 429
16.1.6.3.2 Deals 431
16.1.7 TECSYS 432
16.1.7.1 Business overview 432
16.1.7.2 Products/Services/Solutions offered 433
16.1.7.3 Recent developments 435
16.1.7.3.1 Product launches & upgrades 435
16.1.7.3.2 Deals 437
16.1.8 MCKESSON 438
16.1.8.1 Business overview 438
16.1.8.2 Products/Services/Solutions offered 439
16.1.8.3 Recent developments 441
16.1.8.3.1 Product launches & upgrades 441
16.1.8.3.2 Deals 442
16.1.9 MEDLINE 443
16.1.9.1 Business overview 443
16.1.9.2 Products/Services/Solutions offered 444
16.1.9.3 Recent developments 446
16.1.9.3.1 Product launches & upgrades 446
16.1.9.3.2 Deals 448
16.1.10 GLOBAL HEALTHCARE EXCHANGE, LLC 451
16.1.10.1 Business overview 451
16.1.10.2 Products/Services/Solutions offered 451
16.1.10.3 Recent developments 454
16.1.10.3.1 Product launches & upgrades 454
16.1.10.3.2 Deals 455
16.1.10.3.3 Expansions 456
16.1.11 EPICOR SOFTWARE CORPORATION 457
16.1.11.1 Business overview 457
16.1.11.2 Products/Services/Solutions offered 457
16.1.11.3 Recent developments 460
16.1.11.3.1 Product launches & upgrades 460
16.1.11.3.2 Deals 461
16.1.12 CORCENTRIC, INC. 463
16.1.12.1 Business overview 463
16.1.12.2 Products/Services/Solutions offered 463
16.1.12.3 Recent developments 465
16.1.12.3.1 Product launches & upgrades 465
16.1.12.3.2 Deals 466
16.1.13 COUPA 468
16.1.13.1 Business overview 468
16.1.13.2 Products/Services/Solutions offered 468
16.1.13.3 Recent developments 470
16.1.13.3.1 Product launches & upgrades 470
16.1.13.3.2 Deals 472
16.1.13.3.3 Expansions 473
16.1.14 BLUE YONDER GROUP, INC. 474
16.1.14.1 Business overview 474
16.1.14.2 Products/Services/Solutions offered 475
16.1.14.3 Recent developments 477
16.1.14.3.1 Product Launches & Upgrades 477
16.1.14.3.2 Deals 479
16.1.15 LOGITAG SYSTEMS 481
16.1.15.1 Business overview 481
16.1.15.2 Products/Services/Solutions offered 481
16.1.16 WORKDAY, INC. 483
16.1.16.1 Business overview 483
16.1.16.2 Products/Services/Solutions offered 485
16.1.16.3 Recent developments 486
16.1.16.3.1 Product launches & upgrades 486
16.1.16.3.2 Deals 487
16.1.17 ARVATO SYSTEMS 488
16.1.17.1 Business overview 488
16.1.17.2 Products/Services/Solutions offered 489
16.1.17.3 Recent developments 491
16.1.17.3.1 Product launches & upgrades 491
16.1.17.3.2 Deals 491
16.1.18 CENCORA, INC. 493
16.1.18.1 Business overview 493
16.1.18.2 Products/Services/Solutions offered 494
16.1.18.3 Recent developments 496
16.1.18.3.1 Product launches & upgrades 496
16.1.18.3.2 Deals 497
16.1.18.3.3 Expansions 498
16.1.19 GEP 499
16.1.19.1 Business overview 499
16.1.19.2 Products/Services/Solutions offered 500
16.1.19.3 Recent developments 502
16.1.19.3.1 Product launches & upgrades 502
16.1.19.3.2 Deals 502
16.1.20 VIZIENT, INC. 504
16.1.20.1 Business overview 504
16.1.20.2 Products/Services/Solutions offered 505
16.1.20.3 Recent developments 506
16.1.20.3.1 Product launches & upgrades 506
16.1.20.3.2 Deals 507
16.2 OTHER PLAYERS 508
16.2.1 JUMP TECHNOLOGIES, INC. 508
16.2.2 MEDICAL TRACKING SOLUTIONS, INC. 509
16.2.3 PROMEDEO 510
16.2.4 PROCUREMENT PARTNERS 511
16.2.5 INBEAM TECHNOLOGIES 512

17 RESEARCH METHODOLOGY 513
17.1 RESEARCH APPROACH 513
17.1.1 SECONDARY RESEARCH 513
17.1.1.1 Key data from secondary sources 514
17.1.2 PRIMARY RESEARCH 515
17.1.2.1 Key data from primary sources 516
17.1.2.2 Insights from primary experts 517
17.2 RESEARCH METHODOLOGY 517
17.3 MARKET SIZE ESTIMATION 519
17.4 MARKET BREAKDOWN DATA TRIANGULATION 524
17.5 MARKET SHARE ESTIMATION 525
17.6 STUDY ASSUMPTIONS 525
17.7 LIMITATIONS 526
17.7.1 SCOPE-RELATED LIMITATIONS 526
17.7.2 METHODOLOGY-RELATED LIMITATIONS 526
17.8 RISK ASSESSMENT 526

18 APPENDIX 527
18.1 DISCUSSION GUIDE 527
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 534
18.3 CUSTOMIZATION OPTIONS 536
18.4 RELATED REPORTS 536
18.5 AUTHOR DETAILS 537

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SEGMENTATION 41.
FIGURE 2 MARKET SCENARIO 47.
FIGURE 3 GLOBAL HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2025–2031 47.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2023–2026 48.
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 49.
FIGURE 6 HIGH-GROWTH SEGMENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2026–2031 50.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET DURING FORECAST PERIOD 51.
FIGURE 8 INCREASING DIGITALIZATION AND AUTOMATION OF HEALTHCARE SUPPLY CHAINS TO DRIVE MARKET GROWTH 52.
FIGURE 9 PURCHASING MANAGEMENT ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025 53.
FIGURE 10 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54.
FIGURE 11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56.
FIGURE 12 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 66.
FIGURE 13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: VALUE CHAIN ANALYSIS 70.
FIGURE 14 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ECOSYSTEM ANALYSIS 72.
FIGURE 15 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 77.
FIGURE 16 RECENT FUNDING OF PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 78.
FIGURE 17 PATENT PUBLICATION TRENDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2015–2026 87.
FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT PATENTS, 2015–2026 87.
FIGURE 19 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2015–AUGUST 2026) 88.
FIGURE 20 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING HEALTHCARE SUPPLY CHAIN MANAGEMENT 92.
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 112.
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 113.
FIGURE 23 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT 200.
FIGURE 24 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT 276.
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2021–2025 362.
FIGURE 26 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SHARE ANALYSIS OF KEY PLAYERS (2025) 363.
FIGURE 27 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: BRAND/ PRODUCT COMPARATIVE ANALYSIS 366.
FIGURE 28 EV/EBITDA OF KEY VENDORS 367.
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 367.
FIGURE 30 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 369.
FIGURE 31 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY FOOTPRINT 370.
FIGURE 32 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 376.
FIGURE 33 SAP SE: COMPANY SNAPSHOT 385.
FIGURE 34 ORACLE: COMPANY SNAPSHOT 394.
FIGURE 35 IBM: COMPANY SNAPSHOT 402.
FIGURE 36 CARDINAL HEALTH: COMPANY SNAPSHOT 409.
FIGURE 37 MANHATTAN ASSOCIATES: COMPANY SNAPSHOT 425.
FIGURE 38 TECSYS: COMPANY SNAPSHOT 433.
FIGURE 39 MCKESSON: COMPANY SNAPSHOT 438.
FIGURE 40 MEDLINE: COMPANY SNAPSHOT 444.
FIGURE 41 BLUE YONDER GROUP, INC.: COMPANY SNAPSHOT 475.
FIGURE 42 WORKDAY, INC.: COMPANY SNAPSHOT 484.
FIGURE 43 ARVATO SYSTEMS: COMPANY SNAPSHOT 489.
FIGURE 44 CENCORA, INC.: COMPANY SNAPSHOT 493.
FIGURE 45 RESEARCH DESIGN 513.
FIGURE 46 PRIMARY SOURCES 515.
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 516.
FIGURE 48 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 518.
FIGURE 49 BOTTOM-UP APPROACH 519.
FIGURE 50 TOP-DOWN APPROACH 520.
FIGURE 51 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 521.
FIGURE 52 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: CAGR PROJECTION ANALYSIS 522.
FIGURE 53 DATA TRIANGULATION METHODOLOGY 524.
TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD 44.
TABLE 2 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 67.
TABLE 3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ROLE IN ECOSYSTEM 72.
TABLE 4 INDICATIVE PRICE OF HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY OFFERING (2025) 74.
TABLE 5 INDICATIVE PRICE FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY REGION (2025) 75.
TABLE 6 HEALTHCARE SUPPLY CHAIN MANAGEMENT: KEY CONFERENCES AND EVENTS (2026–2027) 75.
TABLE 7 CASE STUDY 1: IMPROVING SUPPLY CHAIN VISIBILITY ACROSS 70 HOSPITALS AT COMMUNITY HEALTH SYSTEMS 78.
TABLE 8 CASE STUDY: TRANSFORMING SUPPLY CHAIN AT DAYTON CHILDREN’S HOSPITAL 79.
TABLE 9 CASE STUDY 3: OLYMPUS CORPORATION PATH TO EFFICIENT HEALTHCARE SUPPLY CHAIN MANAGEMENT 79.
TABLE 10 CASE STUDY 4: IMPROVING SUPPLY CHAIN EFFICIENCY BY OVERCOMING FORECASTING AND INVENTORY BARRIERS 80.
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES 81.
TABLE 12 TOP APPLICANTS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT 87.
TABLE 13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: KEY PATENTS 89.
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101.
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102.
TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103.
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104.
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104.
TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA 104.
TABLE 20 REGULATORY SCENARIO OF EUROPE 105.
TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC 106.
TABLE 22 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 108.
TABLE 23 REGULATORY SCENARIO OF LATIN AMERICA 109.
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%) 112.
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 113.
TABLE 26 UNMET NEEDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 115.
TABLE 27 END USER EXPECTATIONS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 115.
TABLE 28 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 118.
TABLE 29 HEALTHCARE SUPPLY CHAIN MANAGEMENT SOFTWARE AND THEIR OFFERINGS 119.
TABLE 30 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 119.
TABLE 31 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION) 120.
TABLE 32 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ENTIRE SUPPLY CHAIN SUITES, BY COUNTRY, 2024–2031 (USD MILLION) 121.
TABLE 33 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN PLANNING SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 34 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLIER RELATIONSHIP MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 123.
TABLE 35 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 125.
TABLE 36 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN COST-TO-SERVE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 126.
TABLE 37 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN ANALYTICS SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION) 127.
TABLE 38 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN VISIBILITY SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION) 128.
TABLE 39 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 129.
TABLE 40 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY COUNTRY, 2024–2031 (USD MILLION) 130.
TABLE 41 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR BARCODES & BARCODE SCANNERS, BY COUNTRY, 2024–2031 (USD MILLION) 131.
TABLE 42 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 132.
TABLE 43 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR RFID TAGS & READERS, BY COUNTRY, 2024–2031 (USD MILLION) 133.
TABLE 44 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HARDWARE COMPONENTS, BY COUNTRY, 2024–2031 (USD MILLION) 134.
TABLE 45 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE, BY TYPE, 2024–2031 (USD MILLION) 135.
TABLE 46 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE, BY COUNTRY, 2024–2031 (USD MILLION) 135.
TABLE 47 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANAGED SERVICES, BY COUNTRY 2024–2031 (USD MILLION) 136.
TABLE 48 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 137.
TABLE 49 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 139.
TABLE 50 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 140.
TABLE 51 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 140.
TABLE 52 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 142.
TABLE 53 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROCUREMENT, BY COUNTRY, 2024–2031 (USD MILLION) 143.
TABLE 54 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CAPITAL PURCHASING, BY COUNTRY, 2024–2031 (USD MILLION) 144.
TABLE 55 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR STRATEGIC SOURCING, BY COUNTRY, 2024–2031 (USD MILLION) 146.
TABLE 56 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TRANSPORTATION MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 148.
TABLE 57 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 149.
TABLE 58 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 149.
TABLE 59 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ORDER MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 151.
TABLE 60 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WAREHOUSE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 152.
TABLE 61 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CONSIGNMENT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 153.
TABLE 62 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 155.
TABLE 63 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TISSUE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 156.
TABLE 64 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 158.
TABLE 65 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 159.
TABLE 66 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2024–2031 (USD MILLION) 159.
TABLE 67 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SMALL MOLECULES, BY COUNTRY, 2024–2031 (USD MILLION) 161.
TABLE 68 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 162.
TABLE 69 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONOCLONAL ANTIBODIES, BIOSIMILARS & MRNA, BY COUNTRY, 2024–2031 (USD MILLION) 163.
TABLE 70 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CELL & GENE THERAPY (CGT), BY COUNTRY, 2024–2031 (USD MILLION) 165.
TABLE 71 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2024–2031 (USD MILLION) 166.
TABLE 72 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 167.
TABLE 73 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE FOR MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 167.
TABLE 74 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SURGICAL INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 168.
TABLE 75 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DIAGNOSTICS & THERAPEUTIC EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 170.
TABLE 76 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONITORING DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 171.
TABLE 77 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANTS & PROSTHETICS, BY COUNTRY, 2024–2031 (USD MILLION) 172.
TABLE 78 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 173.
TABLE 79 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2024–2031 (USD MILLION) 174.
TABLE 80 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 176.
TABLE 81 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ON-PREMISE MODELS, BY COUNTRY, 2024–2031 (USD MILLION) 177.
TABLE 82 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2024–2031 (USD MILLION) 179.
TABLE 83 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 181.
TABLE 84 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 182.
TABLE 85 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY COUNTRY, 2024–2031 (USD MILLION) 182.
TABLE 86 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 184.
TABLE 87 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL & SURGICAL DEVICE MANUFACTURERS, BY COUNTRY, 2024–2031 (USD MILLION) 185.
TABLE 88 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 186.
TABLE 89 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY COUNTRY, 2024–2031 (USD MILLION) 186.
TABLE 90 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PRIMARY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2024–2031 (USD MILLION) 188.
TABLE 91 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WHOLESALERS, BY COUNTRY, 2024–2031 (USD MILLION) 189.
TABLE 92 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 191.
TABLE 93 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 192.
TABLE 94 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION) 192.
TABLE 95 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY 2024–2031 (USD MILLION) 194.
TABLE 96 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACIES, BY COUNTRY, 2024–2031 (USD MILLION) 195.
TABLE 97 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 196.
TABLE 98 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION) 197.
TABLE 99 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 199.
TABLE 100 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201.
TABLE 101 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 201.
TABLE 102 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 202.
TABLE 103 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 202.
TABLE 104 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 105 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 203.
TABLE 106 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 107 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 204.
TABLE 108 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 204.
TABLE 109 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 110 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 111 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 206.
TABLE 112 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 206.
TABLE 113 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 206.
TABLE 114 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION) 207.
TABLE 115 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 116 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 208.
TABLE 117 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 118 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 119 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 210.
TABLE 120 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 210.
TABLE 121 US : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 210.
TABLE 122 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 123 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 211.
TABLE 124 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 212.
TABLE 125 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 212.
TABLE 126 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 213.
TABLE 127 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 213.
TABLE 128 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 213.
TABLE 129 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION) 214.
TABLE 130 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 214.
TABLE 131 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 215.
TABLE 132 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 133 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 134 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 217.
TABLE 135 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 217.
TABLE 136 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 217.
TABLE 137 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 218.
TABLE 138 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 218.
TABLE 139 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 140 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 141 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 220.
TABLE 142 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 220.
TABLE 143 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 220.
TABLE 144 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION) 221.
TABLE 145 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 221.
TABLE 146 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 222.
TABLE 147 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 223.
TABLE 148 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 149 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 224.
TABLE 150 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 224.
TABLE 151 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 224.
TABLE 152 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 225.
TABLE 153 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 225.
TABLE 154 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 226.
TABLE 155 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 226.
TABLE 156 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 157 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 227.
TABLE 158 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 227.
TABLE 159 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 228.
TABLE 160 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 228.
TABLE 161 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 228.
TABLE 162 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 229.
TABLE 163 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 230.
TABLE 164 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 230.
TABLE 165 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 166 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 231.
TABLE 167 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 168 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 232.
TABLE 169 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 232.
TABLE 170 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 233.
TABLE 171 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 233.
TABLE 172 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 234.
TABLE 173 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 234.
TABLE 174 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 234.
TABLE 175 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 235.
TABLE 176 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 235.
TABLE 177 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 236.
TABLE 178 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 236.
TABLE 179 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 180 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 181 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 237.
TABLE 182 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 183 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 184 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 239.
TABLE 185 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 239.
TABLE 186 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 240.
TABLE 187 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 240.
TABLE 188 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 240.
TABLE 189 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 190 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 191 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 192 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 242.
TABLE 193 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 243.
TABLE 194 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 243.
TABLE 195 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 244.
TABLE 196 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 244.
TABLE 197 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 244.
TABLE 198 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 245.
TABLE 199 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 245.
TABLE 200 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 246.
TABLE 201 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 246.
TABLE 202 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 247.
TABLE 203 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 247.
TABLE 204 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 247.
TABLE 205 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 248.
TABLE 206 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 248.
TABLE 207 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 249.
TABLE 208 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 249.
TABLE 209 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 250.
TABLE 210 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 250.
TABLE 211 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 250.
TABLE 212 SPAIN : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 251.
TABLE 213 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 251.
TABLE 214 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 252.
TABLE 215 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 252.
TABLE 216 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 253.
TABLE 217 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 253.
TABLE 218 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 253.
TABLE 219 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 254.
TABLE 220 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 254.
TABLE 221 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 254.
TABLE 222 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 255.
TABLE 223 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 256.
TABLE 224 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 256.
TABLE 225 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 257.
TABLE 226 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 257.
TABLE 227 ITALY : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 257.
TABLE 228 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 258.
TABLE 229 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 258.
TABLE 230 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 259.
TABLE 231 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 259.
TABLE 232 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 260.
TABLE 233 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 260.
TABLE 234 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 260.
TABLE 235 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 261.
TABLE 236 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 261.
TABLE 237 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 262.
TABLE 238 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 263.
TABLE 239 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 263.
TABLE 240 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 264.
TABLE 241 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 264.
TABLE 242 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 264.
TABLE 243 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 265.
TABLE 244 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION) 265.
TABLE 245 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 266.
TABLE 246 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 266.
TABLE 247 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 267.
TABLE 248 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 267.
TABLE 249 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION) 267.
TABLE 250 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION) 268.